In this program, experts evaluate risk factors for recurrence in patients with high-risk disease, examining neoadjuvant and adjuvant immunotherapy strategies to improve survival outcomes. Faculty engage in a fast-paced review of clinical data on current and emerging regimens and discuss clinical cases to highlight evidence-based treatment.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/hematology-oncology/20241104/melanoma-insights/overview
- Start Date: 2024-11-22 06:00:00
- End Date: 2024-11-22 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Merck & Co., Inc. - Amount: 37642.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest